View DividendGlaxoSmithKlineE マネジメントマネジメント 基準チェック /04現在、CEO に関する十分な情報がありません。主要情報Hassan Fahmi最高経営責任者n/a報酬総額CEO給与比率n/aCEO在任期間no dataCEOの所有権n/a経営陣の平均在職期間データなし取締役会の平均在任期間データなし経営陣の近況No independent directors Nov 16No independent directors Apr 27すべての更新を表示Recent updatesThird quarter 2024 earnings released: EPS: ج.م0.16 (vs ج.م0.33 in 3Q 2023) Nov 16Investor sentiment improves as stock rises 30% Oct 14Investor sentiment improves as stock rises 15% Sep 22Second quarter 2024 earnings released: EPS: ج.م1.22 (vs ج.م0.07 in 2Q 2023) Aug 18Upcoming dividend of ج.م0.75 per share Jul 11First quarter 2024 earnings released May 18New major risk - Revenue and earnings growth May 03New major risk - Financial data availability Apr 28Investor sentiment deteriorates as stock falls 19% Mar 18Full year 2023 earnings released Mar 07Investor sentiment improves as stock rises 17% Feb 20New major risk - Financial data availability Dec 30New major risk - Earnings quality Aug 30Upcoming dividend of ج.م0.75 per share at 2.3% yield Jun 27Investor sentiment improves as stock rises 23% Apr 04Investor sentiment deteriorates as stock falls 15% Mar 13Upcoming dividend of ج.م3.00 per share Dec 28Investor sentiment deteriorated over the past week Dec 15Investor sentiment improved over the past week Nov 28No independent directors Nov 16Upcoming dividend of ج.م0.75 per share Sep 13No independent directors Apr 27Investor sentiment deteriorated over the past week Feb 15Investor sentiment deteriorated over the past week Nov 21Investor sentiment deteriorated over the past week Oct 20Upcoming dividend of ج.م0.50 per share Jun 28Hikma Pharmaceuticals PLC (LSE:HIK) cancelled the acquisition of GlaxoSmithKline S.A.E (CASE:BIOC).Mar 12Glaxo Group Receives Letter from ACDIMA for Acquisition of Glaxosmithkline SharesFeb 02Hikma Pharmaceuticals PLC (LSE:HIK) entered into a non-binding term sheet to acquire 91.2% stake in GlaxoSmithKline S.A.E (CASE:BIOC) from Glaxo Group Limited.Jan 28Investor sentiment improved over the past week Jan 28New 90-day high: ج.م19.35 Jan 27New 90-day low: ج.م15.15 Dec 21Third quarter 2020 earnings released: ج.م0.17 loss per share Nov 17New 90-day low: ج.م15.22 Nov 02New 90-day high: ج.م18.34 Oct 04New 90-day high - ج.م17.66 Sep 02CEO（最高経営責任者Hassan Fahmi no data在職期間Mr. Hassan Fahmi is Managing Director of GlaxoSmithKline S.A.E.View Ownership
Hikma Pharmaceuticals PLC (LSE:HIK) cancelled the acquisition of GlaxoSmithKline S.A.E (CASE:BIOC).Mar 12
Hikma Pharmaceuticals PLC (LSE:HIK) entered into a non-binding term sheet to acquire 91.2% stake in GlaxoSmithKline S.A.E (CASE:BIOC) from Glaxo Group Limited.Jan 28